The largest database of trusted experimental protocols

Cell proliferation reagent wst 1 assay

Manufactured by Roche
Sourced in Germany

The Cell Proliferation Reagent WST-1 assay is a colorimetric method for the non-radioactive quantification of cell proliferation, cell viability, and cytotoxicity. It utilizes the tetrazolium salt WST-1 to measure the metabolic activity of cells, which directly correlates with the number of viable cells in the culture.

Automatically generated - may contain errors

18 protocols using cell proliferation reagent wst 1 assay

1

Evaluating hASCs Viability with Peptides

Check if the same lab product or an alternative is used in the 5 most similar protocols
The hASCs were grown in DMEM culture medium, supplemented with 10% fetal bovine serum (FBS), at 37 °C, 5% CO2. Briefly, 1 × 104 hASCs were seeded in each well and medium containing the peptide was added to the desired concentration. After incubation for 48 h at 37 °C, the medium was aspirated. Cell metabolic activity was measured with the Cell Proliferation Reagent WST-1 assay (Roche Diagnostics, Mannheim, Germany). Medium containing 10% WST-1 reagent was added to the cells. After 2 h, the supernatant was pipetted out into another 96-well plate, which was then analysed by a TECAN Infinite 200 plate reader at 440 nm (relative to the absorbance at 600 nm. Each peptide was assessed 24 times (3 × 8 samples per round) at each concentration. The positive control was a sample in which no peptide was added. The Live/Dead Viability/Cytotoxicity assay (Invitrogen, Carlsbad, CA, USA) was used to image the live and damaged cells. The samples incubated with peptide for 48 h were washed and incubated with 4 μM of ethidium homodimer-1 and 2 μM of calcein AM at room temperature for 20 min. After washing with PBS, fresh culture medium was added and the cells were imaged under a fluorescence microscope.
+ Open protocol
+ Expand
2

Antiproliferative Effect of Synthesized Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antiproliferative effect of the synthesized compounds was determined using the Cell Proliferation Reagent WST-1 assay (Roche Diagnostics, Mannheim, Germany). The assay principle is based upon the reduction of the tetrazolium salt WST-1 to formazan by mitochondrial dehydrogenases in viable cells.
The tested compounds were exposed at various concentrations of each compound (0.1–100 µg/mL), and then cell viability was quantified by a cell proliferation assay. The generation of the dark yellow colored formazan was measured at 450 nm. The experiments were repeated in triplicate for each tested compound concentration. Calculations of the IC50 values were performed using GraphPad Prism 6 (GraphPad Software, San Diego, CA, USA). The cytotoxic effect of test compounds was compared with cisplatin (positive control).
+ Open protocol
+ Expand
3

Antiproliferative Evaluation of Synthesized Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antiproliferative effect of the synthesized compounds was determined using the Cell Proliferation Reagent WST-1 assay (Roche Diagnostics, Mannheim, Germany). This colorimetric assay is based on the cleavage of the tetrazolium salt WST-1 by mitochondrial dehydrogenases in viable cells, leading to formazan formation. After an exposure to the tested compounds at concentration varying in the range 0.4–400 nM/mL, the cell viability was quantified by a cell proliferation assay. The amount of WST-1-formazan was measured at 450 nm and appropriate calculations were performed as described previously. The cytotoxic activity of the tested compound was compared to the cisplatin (positive control). The experiments were repeated in triplicate for each concentration of the tested compound. The initial concentration of the tested compounds was 1 mg/mL DMSO. Solvent control (DMSO) was included to check that the DMSO had no effect at the concentration used. Calculations of the IC50 values were performed using the GraphPad Prism 6 (GraphPad Software, San Diego, CA, USA).
+ Open protocol
+ Expand
4

Antiproliferative Activity Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Compounds were evaluated for their antiproliferative activity using NHDF (normal human dermal fibroblasts, ATCC, Manassas, VA, USA). The cultured cells were kept at 37 °C and 5% CO2. The cells were seeded (1 × 104 cells/well/100 μL DMEM supplemented with 10% FCS and streptomycin/penicillin) into 96-well plates (Corning Inc., Corning, NY, USA). Cells were counted using a hemocytometer (Burker chamber) and phase contrast Olympus IX50 microscope equipped with Sony SSC-DC58 AP camera and Olympus DP10 digital camera. The cell viability of the compounds was determined using the Cell Proliferation Reagent WST-1 assay (Roche Molecular Biochemicals, Mannheim, Germany). The examined cells were exposed to the tested compounds (1 mg/mL DMSO stock) for 72 h at various concentrations (0.1–100 μg/mL). The control was included in order to eliminate the DMSO effect at the concentration used. Cell cultures were incubated with WST-1 (10 μL) for 1 h. The absorbance of the samples was measured against a background control at 450 nm using a microplate reader with a reference wavelength at 600 nm. The obtained results are expressed as means of at least two independent experiments performed in triplicate. The values of IC50 (compound concentration required to cause 50% inhibition) were calculated from the dose–response relationship with respect to control.
+ Open protocol
+ Expand
5

Ipatasertib Effects on MDA-MB-231 Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells (MDA-MB-231 or MDA-MB-231BR, 5000/well) were seeded in quintuplicates in 96-well-plates, grown for 24h and treated with Ipatasertib (1, 5, 10 or 20µM) or 0.1% DMSO as control by replacing the cell culture medium for 24, 48 and 72h. MDA-MB-231BR AKT1_KO or Ctrl cells were seeded in quintuplicates as described above in cell culture serum-reduced medium and grown for 24, 48 and 72h. Cell viability was determined by Cell Proliferation Reagent WST-1 assay (Roche, Mannheim, Germany) using the manufacturer’s protocol and Microplate Absorbance Reader (Tecan Trading AG, Schweiz). Cell viability values of each cell line after 2 hours were used for normalization. For statistical analyses, each experiment was performed three-times (n=3) and results were given as mean ± S.D.
+ Open protocol
+ Expand
6

Drug Sensitivity Profiling of Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
1000 CTCs, CAFs, A549, or H3122 were plated in each well on a 96-well plate. Each drug concentration had wells in triplicate. Six different concentrations were tested for each drug. Cells were incubated with drugs for 72hrs. After treatment, each well was incubated with Cell Proliferation Reagent WST-1 assay (Roche). Absorbance was measured with Biotek-Synergy Neo-plate Reader. IC50s were determined by nonlinear regression model by Prism Graphpad.
+ Open protocol
+ Expand
7

Evaluating Nanoparticle Impact on Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability was assessed using the Cell Proliferation Reagent WST-1 assay (Roche Diagnostics GmbH, Mannheim, Germany) according to the manufacturer’s instructions. DCs resting or activated with R848 were treated with oxyresveratrol alone or encapsulated in PLGA nanoparticles, or with corresponding amounts of bare PLGA particles for 24 h. After treatment, cell supernatant was removed and 50 µL of pre-warmed fresh complete medium were added to the cells and to 3 empty wells (Blank). A 2× WST solution was freshly prepared by dilution of the 10× WST reagent in the complete medium and a volume of 50 μL was dispensed in the wells and blank. The plate was incubated for 60 min. The absorbance (OD) of the samples was measured using a Victor3 multilabel reader (PerkinElmer, Shelton, CT, USA) at 450 nm.
+ Open protocol
+ Expand
8

Monocyte Viability Assessed by WST-1 Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability was assessed using the Cell Proliferation Reagent WST-1 assay (Roche Diagnostics GmbH, Mannheim, Germany) according to the manufacturer’s instructions. Monocytes resting or activated with β-glucan were treated with oxyresveratrol alone or encapsulated in PLGA nanoparticles, or with corresponding amounts of unloaded PLGA particles for 18 h. After treatment, the cell supernatant was removed and 50 µL of pre-warmed fresh complete medium were added to cells and to three empty wells (blank). A 2× WST solution was freshly prepared by dilution of the 10× WST reagent in the complete medium and a volume of 50 μL was dispensed in the wells and blank. The plate was incubated for 60 min. The absorbance (OD) of the samples was measured using a Victor3 multilabel reader (PerkinElmer, Shelton, CT, USA) at 450 nm.
+ Open protocol
+ Expand
9

Cell Proliferation Assay with WST-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antiproliferative effect of compounds was determined using the Cell Proliferation Reagent WST-1 assay (Roche Diagnostics, Mannheim, Germany). After exposure to tested compounds (at concentrations between 0 and 100 μg/ml) for 72 h, cells were incubated with WST-1 (10 μl) for 1 h, and the absorbance of the samples against a background control was read at 450 nm using with a reference wavelength λ = 600 nm a microplate reader. Results are expressed as means of at least two independent experiments performed in triplicate.
+ Open protocol
+ Expand
10

Cell Proliferation Assay Using WST-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Cell Proliferation Reagent WST-1 assay (Roche, Basel, Switzerland) was performed according to the manufacturer's instructions. HGF were seeded in 96-well plates (10,000 cells/well) and grown for 24 hours. Afterwards, the FBS concentration was reduced to 1% for 24 hours and then the cells were stimulated as described above. Unstimulated cells were used as control. After 24 hours and 48 hours, the WST-1 reagent solution was added to each well (10 µl) and incubated for 3 hours at 37 °C and 5% CO 2 . Subsequently, the absorbance of the samples was determined at 450 nm with 640 nm as the reference wavelength using a microplate reader (SynergyHT).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!